The buoyancy in demand for lab grown diamond jewellery in the US; and Goldiam capturing outsized share of that growing demand helped us post better than expected performance on all front in Q1 FY26. While our top line grew by 39%, our EBITDA margin remained unaffected on account of our nimbleness in cost management; savings in raw material procurement, and our ability to pass on the additional tariffs to customers. All these factors culminated into 38% growth in EBIDTA, and 53% growth in PAT for Q1 FY26.

Goldiam’s market responsiveness, contemporary designs, and large number of SKUs are progressively helping us penetrate deeper within our existing large US customers; and capture higher share of growing demand for LGD jewellery. We are confident of witnessing such robust demand for lab grown diamond jewellery in India as well in the coming years. Adding on to our existing six operational stores, our retail team is relentlessly working on expanding ORIGEM footprint, and in the next few months we will have another 8 operational stores, all at prime locations. We are marking ORIGEM’s entry into malls with one of the most prestigious shopping destinations at two locations, The Phoenix Mills at Lower Parel in Mumbai, and Phoenix Market City at Bengaluru.